• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • GPs

KKR expects lower valuations for its portfolios due to Covid-19

  • Alessia Argentieri
  • Alessia Argentieri
  • 16 April 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

US-based private equity firm KKR expects Covid-19 to lower its portfolio company valuations, as well as reduce its ability to close deals and complete successful exits for its current investments.

"We have concluded that many of our investments will be reduced in value from their prior valuations," said the GP in a SEC filing. "These reductions are driven primarily by actual and expected revenue declines arising out of the Covid-19 pandemic."

KKR expects these reductions in valuation to have an adverse impact on the overall value of its investment portfolio, as well as a corresponding impact on its book value per share, accrued carried interest and assets under management. It also forecasts that some of the factors that drove these declines, particularly period over period revenue declines, will continue in the second quarter of the year.

Furthermore, the GP expects that limitation on travel and social distancing requirements will challenge its ability to market new funds and strategies.

"Fund investors may become restricted by their asset allocation policies to invest in new or successor funds that we provide, because these policies often restrict the amount that they are permitted to invest in alternative assets," added the GP.

KKR forecasts increased difficulty in making new deals and performing successful exits, due to lower valuations, decreased revenues and earnings, lack of potential buyers with financial resources to pursue an acquisition, and volatility in the financial markets.

"While the market dislocation caused by Covid-19 may present attractive investment opportunities, due to increased volatility in the financial markets we may not be able to complete those investments. Our funds may also have more limited opportunities to successfully exit existing investments, or limited or no ability to conduct initial public offerings in equity capital markets, resulting in a reduced ability to realise value from such investments."

Furthermore, KKR expects its portfolio companies to face increased credit and liquidity risk in the future, due to the limited or higher cost of access to preferred sources of funding, which may result in potential impairment of its funds' equity investments. 

"Changes in the debt financing markets are impacting the ability of our portfolio companies to meet their respective financial obligations," said the GP in the statement. "We and our funds may experience similar difficulties, and certain funds have been subject to margin calls when the value of securities that collateralise their margin loan decreased substantially."

The GP also underlined that many of its portfolio companies operate in industries that are materially impacted by Covid-19, including healthcare, travel, entertainment, hospitality, senior living and retail industries, and are facing operational and financial hardships resulting from closure of stores, restrictions on travel, quarantines or stay-at-home orders.

"If the disruptions caused by Covid-19 continue and the restrictions put in place are not lifted, the businesses of these portfolio companies could suffer materially or become insolvent, which would decrease the value of our funds' investments."

KKR also expects an increase in cybersecurity risks linked to remote working and potential loss of productivity, or a delay in the roll out of strategic plans.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • GPs
  • Investments
  • Funds
  • UK / Ireland
  • France
  • Nordics
  • DACH
  • Benelux
  • Southern Europe
  • CEE
  • KKR
  • coronavirus
  • United States

More on GPs

EU foreign subsidies regulations
EU FSR could impact PE fundraising with potential rise in ‘clean funds’

FSR could lead GPs to create funds without foreign LPs; red tape around sovereign wealth funds likely

  • Regulation
  • 01 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Bettina Curtze of Redalpine
Redalpine expands leadership team amid CHF 1bn-plus fundraise

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • Venture
  • 31 August 2023
Canary Wharf and the financial centre of London
IPO offers CVC chance to become multi-asset consolidator

Potential IPO also offers monetisation solution for founders and GP stakes investor Blue Owl

  • GPs
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013